Guangzhou Kingmed Diagnostics Group Co., Ltd.

SHSE:603882 Rapporto sulle azioni

Cap. di mercato: CN¥14.7b

Guangzhou Kingmed Diagnostics Group Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Yaoming Liang

Amministratore delegato

CN¥4.5m

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEO16.0%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneless than a year

Aggiornamenti recenti sulla gestione

Recent updates

Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Weak Earnings May Only Reveal A Part Of The Whole Picture

Nov 06
Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Weak Earnings May Only Reveal A Part Of The Whole Picture

Earnings Tell The Story For Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Sep 27
Earnings Tell The Story For Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next

Sep 03
Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next

Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

Aug 25
Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Jun 04
A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings

May 02
Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings

Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%

Apr 17
Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%

Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking

Feb 28
Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking

AMMINISTRATORE DELEGATO

Yaoming Liang (60 yo)

no data

Mandato

CN¥4,503,500

Compensazione

Mr. Yaoming Liang serves as the Chairman of the Board and General Manager of Guangzhou Kingmed Diagnostics Group Co., Ltd. (formerly known as Guangzhou KingMed Center for Clinical Laboratory Co., Ltd) and...


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Yaoming Liang
Chairman & GMno dataCN¥4.50m15.96%
CN¥ 2.3b
Bixi Hao
Deputy GMno dataCN¥2.62m0.011%
CN¥ 1.7m
Linglai Wang
Deputy GM4.8yrsCN¥1.67m0.13%
CN¥ 19.5m
Ting Yan
Deputy GM & Directorno dataCN¥2.29m0.75%
CN¥ 110.7m
Huobao Xie
Independent Directorless than a yearNessun datoNessun dato
Zhanwen Zeng
Directorno dataCN¥1.04m0.75%
CN¥ 110.7m
Qiang Xie
Directorno dataNessun datoNessun dato
Jianhua Ling
Independent Directorno dataCN¥264.00kNessun dato
Yongjian Chen
Chairman of the Supervisory Boardno dataNessun datoNessun dato
Li Qin Zhou
Supervisorno dataNessun datoNessun dato
Xiaofeng Zou
Employee Representative Supervisorno dataNessun datoNessun dato
Xia Fan
Independent Directorless than a yearNessun datoNessun dato

0.8yrs

Durata media

54.5yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di 603882 non è considerato esperto (durata media del mandato 0.8 anni), il che suggerisce un nuovo consiglio.